Premium
Prognostic factors in renal cell and bladder cancer
Author(s) -
Van Brussel,
Mickisch
Publication year - 1999
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1046/j.1464-410x.1999.00120.x
Subject(s) - erasmus+ , medicine , rotterdam study , library science , urology , general surgery , art , prospective cohort study , art history , computer science , the renaissance
A prognostic marker should be useful in patient management and clinical-decision making, resulting in improved RCC. clinical outcome. However, the ideal prognostic marker has not been Stage discovered for any of the urological malignancies. Few markers are routinely used in clinical decision-making The TNM system, which explicitly defines the anatomical extent of disease, is the most commonly used staging or have been studied in clinical trials. In this review, we discuss the clinical use of tissue-related prognostic factors system. Several studies have shown that stage is the most consistent single prognostic factor to influence in RCC and bladder cancer, and review the published